NEW DELHI: The Centre has directed all states and UTs to ensure the availability of anti-rabies serum at all sub-health centres, primary health centres and urban primary health centres. It has stated that financial support will be provided for the procurement of the anti-rabies serum under the National Health Mission.
Anti rabies serum is administered in cases where there is risk of severe exposure after contact with a rabid animal or an animal is presumed to be rabid. It is to be used in conjunction with rabies vaccine in severe cases. It costs over Rs 10,000 per dose and, doctors say, isn’t available in most primary health centres.
A NHM official in a letter to the states and UTs, stated recently that rabies is a deadly viral infection and availability of medicines for its management and prevention is important to save families from the financial and emotional burden imposed by it. Easy availability of medicines will help in reducing out-of-pocket expenditure borne by patients affected by the disease. The letter also highlighted the need to ensure availability of sickle cell anaemia drug (hydroxyurea), anti-haemophilia factor VII.
Anti rabies serum is administered in cases where there is risk of severe exposure after contact with a rabid animal or an animal is presumed to be rabid. It is to be used in conjunction with rabies vaccine in severe cases. It costs over Rs 10,000 per dose and, doctors say, isn’t available in most primary health centres.
A NHM official in a letter to the states and UTs, stated recently that rabies is a deadly viral infection and availability of medicines for its management and prevention is important to save families from the financial and emotional burden imposed by it. Easy availability of medicines will help in reducing out-of-pocket expenditure borne by patients affected by the disease. The letter also highlighted the need to ensure availability of sickle cell anaemia drug (hydroxyurea), anti-haemophilia factor VII.
Denial of responsibility! Pioneer Newz is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.
